BTOG 2019 Programme V7 Draft .pdf

BTOG 2019 Programme
Continuing Professional Development – accreditation will be applied for from
The Royal College of Pathologists
RCSI Faculty of Radiologists
(Accepted by all Irish Postgraduate Medical Training Bodies)
The Royal College of Surgeons of England
The Federation of the Royal Colleges of Physicians of the United Kingdom

Wednesday 23rd January 2019
10:00 Registration Opens & Refreshments
The BTOG Desk is available for registration/information throughout BTOG 2019.

Ground Floor
Conference Foyer

11:00 – 14:30 BTOG Parallel Symposia (4)
BTOG Translational Oncology Symposium
20 minutes + 10 minutes discussion per speaker
Session 1
Chairs:
Rolf Stahel (CH) and Samreen Ahmed (UK)
11:00
What can we learn from neoadjuvant therapy?
11:30
Can DNA repair be exploited?
12:00
Cancer whole genome sequencing: the GEL legacy
12:30 – 13:00 Lunch and Exhibition

Session 2
Chairs:
13:00
13:30
14:00

Denis Talbot (UK) and Alastair Greystoke (UK)
TKI resistance: lessons learned from ALK
Adoptive cell therapy for solid tumours:
what you need to know
Targeting KRAS: hopeless or hopeful?

14:30 – 15:00 Refreshments and Exhibition

Herbert

Fred Hirsch (US)
Ken O’Byrne (AU)
Nirupa Murugaesu (UK)

Ground Floor
Conference Foyer

Ross Camidge (US)
Sophie Papa (UK)
Udai Banerji (UK)

Ground Floor
Conference Foyer

Faculty in red are to be confirmed
Version 7 Draft – 04.12.18 – the programme is subject to change/availability
1

Wednesday 23rd January 2019
BTOG Radiotherapy Symposium
Session 1
Chairs:
11:00
11:15
11.30
11:45
12.00
12:15

Stage III NSCLC Update
Stephen Harrow (UK) and Matthew Hatton (UK)
National Data on Management of Stage III NSCLC
Technology matters
Questions and discussion
Patient selection & systemic therapy update
Immuno-Toxicity: lessons learnt from advanced disease
Questions and discussion

12:30 – 13:00 Lunch and Exhibition
Session 2
Chairs:
13:00
13:30

14.00
14:10

Stereotactic Radiotherapy Update
Clive Peedell (UK) and Kevin Franks (UK)
Synchronous, metachronous oligometastatic &
oligoprogressive NSCLC: Current data
Early stage disease: Optimal approach with
central / ultracentral lesions
National Data on Management of Early Stage Disease
Questions and discussion

14:30 – 15:00 Refreshments and Exhibition

BTOG Diagnostic Symposium

Pembroke

Susan Harden (UK)
Marianne Aznar (UK)
Jason Lester (UK)
Tom Newsom-Davis (UK)
Ground Floor
Conference Foyer

Alexander Louie (CA)
Matthias Guckenberger
(CH)
Iain Phillips (UK)

Ground Floor
Conference Foyer
Fitzwilliam

20 minutes + 10 minutes discussion per speaker
Session 1 The Optimal Supportive Care Pathway
Chairs:
Vanessa Beattie (UK) and Vidan Masani (UK)
11:00
Practical Delivery of Enhanced Recovery
Babu Naidu (UK)
11:30
Getting Ready for Treatment - Supportive Care Perspective Barry Laird (UK)
12:00
Managing Tobacco Addiction in the Optimal Pathway
John Britton (UK)
12:30 – 13:00 Lunch and Exhibition
Session 2
Chairs:
13:00
13:30
14:00

Practical Implementation of LDCT Screening
David Baldwin (UK) and Sam Janes (UK)
Significant Incidental Findings: Harm or Benefit
and What to Do
Nodule Management: BTS vs Fleischner & the role of
Volumetry, CAD and AI
Upskilling the Workforce: Image-guided Biopsy
of Subcentimetre Nodules

14:30 – 15:00 Refreshments and Exhibition

2

Ground Floor
Conference Foyer

Richard Booton (UK)
Fergus Gleeson (UK)
Anna Sharman (UK)
Ground Floor
Conference Foyer

Wednesday 23rd January 2019
Association of Pulmonary Pathologists
APP/BTOG Symposium

Meeting Room 6, 1st Floor

20 minutes + 10 minutes discussion per speaker
Session 1: Lung Cancer Diagnostics in 2020; the View from Pathology
Chair:
Emily Shaw (UK)
11:00
Detecting the drivers; what, when and how
Matt Evans (UK)
11:30
Protein expression as predictive markers; PD-L1, DLL3
and beyond
Alex Haragan (UK)
12:00
Role of the pathologist in the genomic age; gathering,
interpreting and integrating the data
David Moore (UK)
12:30 – 13:00 Lunch and Exhibition
Session 2:
Chairs:
13:00
13:15
13:30
13:45
14:00
14:15

Ground Floor
Conference Foyer

Case presentations: A Selection of the Weird and the Wonderful
Siobhan Nicholson (IE) and Aurelie Fabre (IE)
Case 1
Case 2
Case 3
Case 4
Case 5
Case 6

14:30 – 15:00 Refreshments and Exhibition

Ground Floor
Conference Foyer

15:00 – 19:45 Sponsored Satellite Symposia
45 minutes per satellite symposium
15:00

Satellite symposium sponsored by AstraZeneca

16:00

Satellite symposium sponsored by Takeda

17:00

Satellite symposium sponsored by Roche

18:00

Satellite symposium sponsored by AstraZeneca

19:00

Satellite symposium sponsored by MSD

19:45

Close

20:00 – 21:30 BTOG Welcome Reception
3

Herbert

Ground Floor
Conference Foyer

Thursday 24th January 2019
07:30 Registration Opens & Refreshments
The BTOG Desk is available for registration/information throughout BTOG 2019

Ground Floor
Conference Foyer

09:00 – 10:50 Session 1
09:00
09:20
09:30
09:40

Welcome - BTOG
NCRI
ETOP
EORTC

Session 1
Chairs:

Plenary Session
Des Carney (IE) and John Field (UK)
20 minutes + 10 minutes discussion per speaker
NELSON’s impact in Europe
The PACIFIC & beyond: will immunotherapy cure
lung cancer?

09:50
10:20

Pembroke/Herbert
Sanjay Popat (UK)
Matthew Hatton (UK)
Rolf Stahel (CH)
Anne-Marie Dingemans (NL)

Harry De Koning (NL)
Martin Reck (DE)

10:50 – 11:20 Refreshments, Exhibition and Posters

Ground Floor
Conference Foyer

11:20 – 13:00 Sessions 2 & 3
Session 2
Chairs:
11:20
11:45
Session 3
Chairs:
12:10
12:12
12:23
12:34

12:45
12:56
13:00
4

Pembroke/Herbert
John Gosney (UK) and Robert Rintoul (UK)
15 minutes + 10 minutes discussion per speaker
The CRUK ACE programme: future policy lessons
Sara Hiom (UK)
Pathology specimens in the immuno-NGS era: quality or quantity? Keith Kerr (UK)
Poster Oral Presentations
Matthew Callister (UK) and Cindy Billingham (UK)
Introduction - 7 minutes + 4 minutes discussion per speaker
Psychological impact of low-dose CT screening in a ‘real world’
demonstration lung cancer screening pilot
Impact of radiographer immediate reporting of chest X-rays from
general practice on the lung cancer pathway (radioX)
Modified Lung Immune Predictive Index (mLIPI) as a predictive
tool of nivolumab outcomes and immune related adverse events
in advanced non-small cell lung cancer (NSCLC) patients
PD-L1 expression in resected non-small cell lung cancer;
variation between primary tumour and nodal metastases
Closing comments
Close

Sonja Kummer
Nicholas Woznitza
Ken O’Byrne
Alexander Haragan

Thursday 24th January 2019
13:00 – 14:00 Lunch, Exhibition and Posters

Ground Floor
Conference Foyer

13:10 - 13:50 Sponsored Satellite Symposia
13:10

Satellite symposium sponsored by Pfizer

Pembroke/Herbert

14:00 – 15:30 Session 4:
Pembroke/Herbert
Session 4
Chairs:
14:00
14:05
14:20
14:35
14:50
15:05

Multidisciplinary Management of
Thymic Epithelial Malignancies
Alan Kirk (UK) and Louise Burke (IE)
An introduction to ITMIG
The surgical approach
Pathology of thymic epithelial malignancies
Oncological management
Pre-op optimization & peri-op care
Panel and audience discussion

15:30 – 16:00 Exhibition and Posters

16:00 – 18:00 Collaborative Sessions
Please see next page.

5

Alan Kirk (UK)
Frank Detterbeck (US)
Andrew Nicholson (UK)
David Gilligan (UK)
Isabel Leite (UK)

Ground Floor
Conference Foyer

Thursday 24th January 2019
16:00 – 17:00 Parallel Sessions (3)
BTOG/NCRI LOcoRegionalDiagnosis (LORD)
Subgroup Update
Chair:
16:00

17:00

Mary O’Brien (UK)
Open
How much surgery is necessary for stage I disease?
A neoadjuvant IO study
The non durva stage III patients – what to do?
Close

BTOG/NCRI Mesothelioma
Subgroup Update
Chair:
16:00
16:05
16:15
16:25
16:30
16:35
16:45
16:55
17:00

Peter Szlosarek (UK)
Introduction
ATOMIC
MARS2
MESOTRAP
CONFIRM
MIST
BEAT-meso
Gaps and new proposals
Close

Association of Pulmonary Pathologists
APP Business Meeting
Chairs:
16:00
18:00

6

John Gosney (UK)
Open
Close

Pembroke

Carol Tan (UK)
TBC
TBC

Herbert

Peter Szlosarek (UK)
Peter Szlosarek (UK)
Eric Lim (UK)
Robert Rintoul (UK)
Dean Fennell (UK)
Dean Fennell (UK)
Sanjay Popat (UK)
Peter Szlosarek (UK)

Meeting Room 6, 1st Floor

17:00 – 18:00 Parallel Sessions (4)
Pembroke

BTOG/NCRI Advanced Disease
Subgroup Update
Chair:
17:00
18:00

Fiona Blackhall (UK)
Open
Close

BTOG/NCRI Screening and Early Diagnosis
Subgroup Update - Optimising Lung Cancer Screening
Chair:
17:00
17:20
17:40
18:00

Neal Navani (UK)
Improving risk models for participant selection
Understanding patient experiences of screening
Integrating biomarkers into screening
Close

BTOG/NLCFN Nursing Session
Chairs:
17:00

17:25

18:00

Chairs:
16:00
18:00

David Baldwin (UK)
Samantha Quaife (UK)
Philip Crosbie (UK)

Meeting Room 1 & 2, 1st Floor

Vanessa Beattie (UK) and Angela Tod (UK)
20 Minutes + 5 minutes discussion
Development and evaluation of a self-management
intervention for the breathlessness-cough-fatigue
symptom cluster in lung cancer
7 minutes + 3 minutes discussion per speaker
Prospective, multi-centre review to identify readmission
rates and causes within 30-days of discharge following
primary lung cancer surgery
Patient needs regarding the recovery package
A randomised controlled Trial to Investigate the
effectiveness of a nutritional Intervention to enhance
patient Recovery after elective major lung
SurgerY-ThIRStY Feasibility Study
Close

Association of Pulmonary Pathologists
APP Business Meeting

Herbert

Janelle Yorke (UK)

Maureen King (UK)
Josie Roberts (UK)

Amy Kerr (UK)

Meeting Room 6, 1st Floor

John Gosney (UK)
Open
Close

19:30 – 20:00 BTOG Reception
Ground Floor
Conference Foyer

20:00 – 23:00 17th Annual BTOG 2019 Conference Dinner
Dress code: Gents - lounge suit and tie or black tie / Ladies - cocktail wear
The conference dinner is ticket only and must be pre-booked and includes
presentation of the BTOG Lifetime Achievement Award 2019 and poster awards.
7

Pembroke/Herbert

Friday 25th January 2019
09:00 – 10:30 Session 5: Lung Cancer Screening in the UK
Pembroke/Herbert
David Gilligan (UK)
Neal Navani (UK)
Michael Peake (UK)

09:00
09:05
09:10

Roy Castle Lung Cancer Foundation Grants
National Lung Cancer Audit Report
UKLCC Molecules Matter Report

Session 5
Chairs:
09:15
09:30
09:45
10:00
10:15

Implementing Lung Cancer Screening in the UK - if, when and how?
Matthew Callister (UK) and Richard Booton (UK)
The National Screening Committee view post NELSON
Bob Steele (UK)
Who will read the scans?
Anand Devaraj (UK)
Who will resect the cancers and how?
Tim Batchelor (UK)
How do we best integrate smoking cessation?
Rachael Murray (UK)
Panel and audience discussion

10:30 – 11:00 Refreshments, Exhibition and Posters

Ground Floor
Conference Foyer

11:00 – 12:30 Session 6: Implementing Optimal Practice
Session 6
Chairs:
11:00
11:15
11:30
11:45
12:00

How to use your Post-operative Histopathology Report:
Everything you want to know but are afraid to ask
Yvonne Summers (UK) and Jackie Fenemore (UK)
The pathologist’s view
The surgeon’s view
The medical oncologist’s view
The radiation oncologist’s view
Panel and audience discussion

12:30 – 13:30 Lunch, Exhibition and Posters

Pembroke/Herbert

Paul Cane (UK)
John Edwards (UK)
Tanya Ahmad (UK)
TBC
Ground Floor
Conference Foyer

13:30 - 15:00 Session 7: UK Impact of Trial Data
Session 7
Chairs:
13:30
13:50
14:15
14:40
15:00

8

Pembroke/Herbert
Sinead Cuffe (IE) and James Spicer (UK)
Includes 5 minutes discussion per speaker
Radical treatment for oligometastatic NSCLC: should it
be standard care?
Can we treat mesothelioma cachexia?
Will immunotherapy change outcomes in SCLC
Nurse led systemic therapy delivery in immunotherapy era
Close

Fiona McDonald (UK)
Andrew Kidd (UK)
Michaela Higgins (IE)
Sandra Wakelin (UK)